Provention Bio begins Phase IIa systemic lupus erythematosus trial
Hong Kong (China SAR)
Inmagene, HUTCHMED begin Phase I dosing of atopic dermatitis asset
Inmagene assumed the development responsibility of IMG-007 at the candidate stage.
COVID-19 coronavirus: Top ten most-affected countries
Cocrystal Pharma to study hepatitis C drug in Hong Kong
M&As this week: Zymergen, Celgene Corp, China Biology Services Group Limited
Deals this week: AmpliPhi Biosciences, Argos Therapeutics, Juvenescence Limited
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox